MedTrace Logo

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

NCT01954264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2421

Last updated 2020-01-21

Study results available
· View outcomes & findings →

Summary

This study is designed to characterise P. falciparum transmission intensity in subjects aged ≥6 months and \<10 years by measurement of P. falciparum parasite prevalence, and to estimate the use of malaria control interventions at some centres selected for the EPI-MAL-002 and EPI-MAL-003 studies in sub-Saharan Western Africa.

Conditions

Interventions

PROCEDURE

Capillary blood sample

Capillary blood sample (up to 200µL) for determination of PP (blood slides).

OTHER

Data collection

Prospective data collection at the study visit by the internet based Electronic Case Report Form (eCRF)

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-19
Primary Completion
2013-11-22
Completion
2013-11-25

Countries

  • Burkina Faso
  • Senegal

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01954264 on ClinicalTrials.gov